Tepezza is a monoclonal antibody (mAb) pharmaceutical product
Tepezza is a monoclonal antibody (mAb) pharmaceutical product
… Tepezza (teprotumumab-trbw) is FDA approved just in time for Rare Disease Day

Horizon Therapeutics Introduces Tepezza (teprotumumab-trbw)

Tepezza is the first FDA-approved therapy for the treatment of active Thyroid Eye Disease

Tepezza is an advanced pharmaceutical therapy

Thyroid eye disease challenges

Deputy Director of the Division of Transplant and Ophthalmology Products in the FDA’s Center for Drug Evaluation and Research Wiley Chambers MD provides these insights about Tepezza:

Horizon will conduct a post-approval study for Tepezza

Horizon Therapeutics corporate information

Written by

Authentic, fact-based healthcare content marketing writing for medical, business, academic, patient and consumer audiences https://www.BareSkyMarketing.com/

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store